131 related articles for article (PubMed ID: 28322780)
1. Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes.
Malátková P; Skarka A; Musilová K; Wsól V
Chem Biol Interact; 2017 Oct; 276():121-126. PubMed ID: 28322780
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of fenofibric acid by carbonyl reducing enzymes.
Malátková P; Kanavi M; Nobilis M; Wsól V
Chem Biol Interact; 2016 Oct; 258():153-8. PubMed ID: 27599626
[TBL] [Abstract][Full Text] [Related]
3. Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.
Malátková P; Sokolová S; Chocholoušová Havlíková L; Wsól V
Biochem Pharmacol; 2016 Jun; 109():83-90. PubMed ID: 27055738
[TBL] [Abstract][Full Text] [Related]
4. The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man.
Malátková P; Havlíková L; Wsól V
Chem Biol Interact; 2014 Sep; 220():241-7. PubMed ID: 25063510
[TBL] [Abstract][Full Text] [Related]
5. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
Atalla A; Breyer-Pfaff U; Maser E
Xenobiotica; 2000 Aug; 30(8):755-69. PubMed ID: 11037109
[TBL] [Abstract][Full Text] [Related]
7. Sex hormones reduce NNK detoxification through inhibition of short-chain dehydrogenases/reductases and aldo-keto reductases in vitro.
Stapelfeld C; Maser E
Chem Biol Interact; 2017 Oct; 276():167-173. PubMed ID: 28257955
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism and identification of human enzymes involved in the metabolism of methylnaltrexone.
Tong Z; Chandrasekaran A; Li H; Rotshteyn Y; Erve JC; Demaio W; Talaat R; Hultin T; Scatina J
Drug Metab Dispos; 2010 May; 38(5):801-7. PubMed ID: 20173089
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine.
Hirosawa K; Fujioka H; Morinaga G; Fukami T; Ishiguro N; Kishimoto W; Nakase H; Mizuguchi H; Nakajima M
Drug Metab Dispos; 2023 Dec; 51(12):1569-1577. PubMed ID: 37722844
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis.
El-Hawari Y; Favia AD; Pilka ES; Kisiela M; Oppermann U; Martin HJ; Maser E
Chem Biol Interact; 2009 Mar; 178(1-3):234-41. PubMed ID: 19061875
[TBL] [Abstract][Full Text] [Related]
11. Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases.
Rosemond MJ; St John-Williams L; Yamaguchi T; Fujishita T; Walsh JS
Chem Biol Interact; 2004 Mar; 147(2):129-39. PubMed ID: 15013815
[TBL] [Abstract][Full Text] [Related]
12. Carbonyl reductase sniffer from the model organism daphnia: Cloning, substrate determination and inhibitory sensitivity.
Strehse JS; Protopapas N; Maser E
Chem Biol Interact; 2019 Jul; 307():29-36. PubMed ID: 30991043
[TBL] [Abstract][Full Text] [Related]
13. Carbonyl reduction of mequindox by chicken and porcine cytosol and cloned carbonyl reductase 1.
Tang X; Mu P; Wu J; Jiang J; Zhang C; Zheng M; Deng Y
Drug Metab Dispos; 2012 Apr; 40(4):788-95. PubMed ID: 22266778
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human short chain dehydrogenase/reductase SDR16C family members related to retinol dehydrogenase 10.
Adams MK; Lee SA; Belyaeva OV; Wu L; Kedishvili NY
Chem Biol Interact; 2017 Oct; 276():88-94. PubMed ID: 27793605
[TBL] [Abstract][Full Text] [Related]
15. Carbonyl reduction of bupropion in human liver.
Molnari JC; Myers AL
Xenobiotica; 2012 Jun; 42(6):550-61. PubMed ID: 22339467
[TBL] [Abstract][Full Text] [Related]
16. Human carbonyl reductases.
Malátková P; Maser E; Wsól V
Curr Drug Metab; 2010 Oct; 11(8):639-58. PubMed ID: 20942781
[TBL] [Abstract][Full Text] [Related]
17. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
[TBL] [Abstract][Full Text] [Related]
18. Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro.
Skarydova L; Nobilis M; Wsól V
Xenobiotica; 2013 Apr; 43(4):346-54. PubMed ID: 23020786
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers.
Amai K; Fukami T; Ichida H; Watanabe A; Nakano M; Watanabe K; Nakajima M
Drug Metab Pharmacokinet; 2020 Dec; 35(6):539-547. PubMed ID: 33036882
[TBL] [Abstract][Full Text] [Related]
20. Chinese hamster monomeric carbonyl reductases of the short-chain dehydrogenase/reductase superfamily.
Miura T; Nishinaka T; Takama M; Murakami M; Terada T
Chem Biol Interact; 2009 Mar; 178(1-3):110-6. PubMed ID: 18983989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
